Patent · US Active

Baculovirus expression system

US12385014B2 · kind B2 · utility

0Cited by
1References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 4, 2017
Grant dateAug 12, 2025
Priority date
Expiry dateDec 3, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/14151
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to a method for producing a recombinant baculovirus comprising n exogenous genes in an insect cell, by means of homologous recombination of a replication-deficient baculovirus genome and n transfer vectors, each comprising one of the n exogenous genes, n being an integer at least equal to 2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.